alt

Panos Deloukas

Panos Deloukas

Panos Deloukas is Chair of Cardiovascular Genomics and Director William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London (QMUL). He is Fellow of The Academy of Medical Sciences (UK) since 2018. Deloukas is a world leader in complex trait genetics investigating the molecular basis of cardio-metabolic traits. He co-leads global consortia in common disease genetics (CARDIoGRAMplusC4D, GLGC, GIANT) having identified many of the loci underpinning lipid levels and coronary heart disease. He has authored over 534 publications (H-index 191) and is amongst the world’s top 1% highly cited researchers in Molecular Biology & Genetics.


Current position

  • Director William Harvey Research Institute (1/10/2020 - )

  • Non-clinical Professor of Cardiovascular Genomics, William Harvey Research Institute, Queen Mary University of London (1/9/2013 - )

  • Dean for Life Sciences, Queen Mary University of London, London, UK (1/11/17 - )


Academic qualifications

Aristotelian University of Thessaloniki, BS, Chemistry July 1986

University Paris VII, MSc Microbiology September 1987

Biozentrum, Switzerland DPhil, Molecular Biology June 1992

 

Measures of esteem

  • Fellow of the European Society of Cardiology (FESC) since May 2010

  • Co-Chair of CardiogramPlus since June 2010

  • Member of the Steering Committee of the Global Lipids Genetic Consortium since  2010

  • Member of the Cardiovascular GeCIP and Lead of the functional subgroup since  2015

  • Member of the Steering Committee of the BRC-PRS Collaborative and Co-Chair of the Cardiovascular, Metabolic, Endocrine, Multimorbidity, Haematology working group (August 2021 - )

  • Highly Cited Researchers sequentially 2014-2020 as well as in the top 200 influential scientists in Molecular Biology & Genetics for the period 2002-2012

  • Fellow of the The Academy of Medical Sciences (UK), elected May 2018

  • In 2023 Edition of  Research.com for Best Scientists in the field of Genetics, he was ranked #18 in the world


Research grants (active)

  • BHF Accelerator award £1,000,000 2019-2024 co-applicant

  • NIHR Artificial Intelligence for Multiple Long-Term Conditions: Using deep learning approaches to examine serious mental illness and physical multimorbidity across the life-course: from mechanisms towards novel interventions   £100,000 2021-2023

  • BHF PhD studentship FS/19/62/34901D (4 year programme) - Investigating risk factors for NAFLD/NASH and identifying their causality to the disease   £163354  2019 - 2023

  • Bart’s Charity PhD studentship Functional Analysis of Coronary Artery Disease Risk Variants  £157,866 2022-2026

  • MEDCITY Collaborate to Innovate: London Diagnostics   -  AI tool for cardiovascular risk using polygenic and transcriptomic profiling   £100,000   2022-2024

  • NIHR BRC(5 year programme). Barts Biomedical Research Centre. £20,994,785 2022-2027 Theme co-Lead: Precision Cardiovascular Genomic Medicine (£6,025,790)

  • Foreign, Commonwealth, and Development Office - Gulf Strategy Fund: UK-Qatar Precision Healthcare Collaborative   £741,108 2022-2025  (Deloukas is Theme lead: Priming cardiometabolic disease prevention in the Qatar & UK population through integration of polygenic risk scores and health data £179,000)

  • Horizon: BETTER4U Preventing obesity through Biologically and bEhaviorally Tailored inTERventions for you – (10m Euros 2023-2027). Deloukas is co-investigator for QMUL (£367,415 through UKRI)

  • NHS Genomic Networks of Excellence – Cardiovascular Network of Excellence, Deloukas Leads Theme 2: Exploring the clinical utility of novel AI-based Integrated Risk Score (IRS) for cardiovascular disease (CVD) (£190,000 2023-2025)

  • HORIZON-HLTH-2023: NEXT GENeration tools for genome-centric multimodal data integration in personalised cardiovascular medicine (2023-2027, 9,997,976 Euro) Deloukas is co-PI for QMUL (2m Euro)